MARKET

IMVT

IMVT

Immunovant Inc
NASDAQ
34.84
+4.31
+14.12%
Opening 15:32 11/09 EST
OPEN
33.00
PREV CLOSE
30.53
HIGH
35.61
LOW
32.81
VOLUME
2.83M
TURNOVER
--
52 WEEK HIGH
45.42
52 WEEK LOW
21.43
MARKET CAP
7.20B
P/E (TTM)
-12.3973
1D
5D
1M
3M
1Y
5Y
1D
Healthcare Stocks Rally: EDSA And DCTH Jump 30%, VIR And IMVT Also Gain
NASDAQ · 1h ago
Immunovant Meets Primary Endpoint In Difficult-To-Treat Rheumatoid Arthritis Study
Benzinga · 3h ago
Immunovant, Inc. Reports IMVT-1402 Clinical Updates and Financial Results for the Quarter Ended September 30, 2026
NASDAQ · 4h ago
Immunovant rises 15.4%
TipRanks · 6h ago
Immunovant (IMVT) Jumped, What Is Driving Attention Today?
Simply Wall St · 7h ago
Immunovant reports Q2 EPS (47c), consensus (72c)
TipRanks · 8h ago
Immunovant files automatic mixed securities shelf
TipRanks · 8h ago
Immunovant Files Prospectus For Offering Mixed Shelf; Terms Undisclosed
Benzinga · 8h ago
More
About IMVT
Immunovant, Inc. is a clinical-stage immunology company enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-fragment crystallizable receptor (FcRn) technology, the Company is developing targeted therapies to meet the complex and variable needs of people with autoimmune diseases. Its product pipeline includes its product candidates, IMVT-1402 and batoclimab, both of which are novel, fully human, monoclonal antibodies that target the neonatal FcRn. Subcutaneous injections, IMVT-1402 and batoclimab have been observed to reduce immunoglobulin G (IgG) antibody levels, which has provided evidence supporting the use of an anti-FcRn antibody in disease areas associated with high levels of pathogenic IgG antibodies. The Company is developing batoclimab for myasthenia gravis (MG), thyroid eye disease (TED), chronic inflammatory demyelinating polyneuropathy (CIDP) and Graves’ disease (GD).

Webull offers Immunovant Inc stock information, including NASDAQ: IMVT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMVT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMVT stock methods without spending real money on the virtual paper trading platform.